Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
8
pubmed:dateCreated
2009-6-8
pubmed:abstractText
Danhong Injection (DHI), a Chinese Materia Medica standardized product extracted from Radix Salviae Miltiorrhizae and Flos Carthami tinctorii, has the actions of promoting blood circulation and resolving stasis to promote regeneration. The clinical therapeutic effects of DHI on traumatic intracranial hematoma (TICH) were observed. Eighty patients with TICH were randomly assigned to trial group and a control group (40 patients per group), and all were administered with routine medication. Additionally, DIH was administered intravenously to patients in the trial group. Pre and post-treatment GCS was observed in the two groups, along with GOS after therapy. The intracranial hematoma absorption, hemorheological changes, and changes in coagulation indexes pre- and post-treatment were evaluated. The results indicated that GCS and GOS after therapy for the trial group were superior to those for the control group (p<0.05). There was a significant post-treatment difference in the intracranial hematoma absorption between the two groups (p<0.01). Each hemorheological index in the trial group improved significantly as compared with that of the control group (p<0.05 or p<0.01). The plasma levels of fibrinogen and D-dimer in the trial group were significantly decreased after therapy (p<0.01). These results suggest that DHI is conducive to the recovery of patients with TICH.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
1618-095X
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
16
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
683-9
pubmed:meshHeading
pubmed-meshheading:19427180-Absorption, pubmed-meshheading:19427180-Adolescent, pubmed-meshheading:19427180-Adult, pubmed-meshheading:19427180-Blood Viscosity, pubmed-meshheading:19427180-Cardiovascular Agents, pubmed-meshheading:19427180-Carthamus, pubmed-meshheading:19427180-Coma, pubmed-meshheading:19427180-Drugs, Chinese Herbal, pubmed-meshheading:19427180-Erythrocyte Aggregation, pubmed-meshheading:19427180-Female, pubmed-meshheading:19427180-Fibrin Fibrinogen Degradation Products, pubmed-meshheading:19427180-Fibrinogen, pubmed-meshheading:19427180-Flowers, pubmed-meshheading:19427180-Humans, pubmed-meshheading:19427180-Intracranial Hemorrhage, Traumatic, pubmed-meshheading:19427180-Male, pubmed-meshheading:19427180-Medicine, Chinese Traditional, pubmed-meshheading:19427180-Middle Aged, pubmed-meshheading:19427180-Phytotherapy, pubmed-meshheading:19427180-Plant Extracts, pubmed-meshheading:19427180-Plant Roots, pubmed-meshheading:19427180-Plants, Medicinal, pubmed-meshheading:19427180-Salvia miltiorrhiza, pubmed-meshheading:19427180-Young Adult
pubmed:year
2009
pubmed:articleTitle
Clinical observation of Danhong Injection (herbal TCM product from Radix Salviae miltiorrhizae and Flos Carthami tinctorii) in the treatment of traumatic intracranial hematoma.
pubmed:affiliation
Department of Traditional Chinese Medicine, Second Affiliated Hospital Zhejiang University College of Medicine, Hangzhou, Zhejiang, PR China.
pubmed:publicationType
Journal Article, Randomized Controlled Trial